386 related articles for article (PubMed ID: 33994711)
1. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.
Sunil Kumar N; Remalayam B; Thomas V; Ramachandran TM; Sunil Kumar K
J Clin Exp Hepatol; 2021; 11(2):163-170. PubMed ID: 33746440
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients.
Devarbhavi H; Patil M; Reddy VV; Singh R; Joseph T; Ganga D
Liver Int; 2018 Jul; 38(7):1322-1329. PubMed ID: 29222960
[TBL] [Abstract][Full Text] [Related]
4. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
[TBL] [Abstract][Full Text] [Related]
5. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
6. Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.
Rathi C; Pipaliya N; Patel R; Ingle M; Phadke A; Sawant P
Ann Hepatol; 2017; 16(3):442-450. PubMed ID: 28425415
[TBL] [Abstract][Full Text] [Related]
7. Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.
Lo Re V; Haynes K; Forde KA; Goldberg DS; Lewis JD; Carbonari DM; Leidl KB; Reddy KR; Nezamzadeh MS; Roy J; Sha D; Marks AR; De Boer J; Schneider JL; Strom BL; Corley DA
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2360-8. PubMed ID: 26122767
[TBL] [Abstract][Full Text] [Related]
8. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality.
Devarbhavi H; Dierkhising R; Kremers WK; Sandeep MS; Karanth D; Adarsh CK
Am J Gastroenterol; 2010 Nov; 105(11):2396-404. PubMed ID: 20648003
[TBL] [Abstract][Full Text] [Related]
9. An Update on Drug-induced Liver Injury.
Devarbhavi H
J Clin Exp Hepatol; 2012 Sep; 2(3):247-59. PubMed ID: 25755441
[TBL] [Abstract][Full Text] [Related]
10. Liver injury during durvalumab-based immunotherapy is associated with poorer patient survival: A retrospective analysis.
Swanson LA; Kassab I; Tsung I; Schneider BJ; Fontana RJ
Front Oncol; 2022; 12():984940. PubMed ID: 36353563
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C
Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
[TBL] [Abstract][Full Text] [Related]
14. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis.
Anand AC; Nandi B; Acharya SK; Arora A; Babu S; Batra Y; Chawla YK; Chowdhury A; Chaoudhuri A; Eapen EC; Devarbhavi H; Dhiman R; Datta Gupta S; Duseja A; Jothimani D; Kapoor D; Kar P; Khuroo MS; Kumar A; Madan K; Mallick B; Maiwall R; Mohan N; Nagral A; Nath P; Panigrahi SC; Pawar A; Philips CA; Prahraj D; Puri P; Rastogi A; Saraswat VA; Saigal S; Shalimar ; Shukla A; Singh SP; Verghese T; Wadhawan M;
J Clin Exp Hepatol; 2020; 10(4):339-376. PubMed ID: 32655238
[TBL] [Abstract][Full Text] [Related]
15. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
Teschke R; Danan G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
[TBL] [Abstract][Full Text] [Related]
16. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study.
Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653
[No Abstract] [Full Text] [Related]
17. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
Teschke R; Méndez-Sánchez N; Eickhoff A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
[TBL] [Abstract][Full Text] [Related]
18. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).
Teschke R; Danan G
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800917
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Risk Factors for Drug-Induced Liver Injury: A Retrospective Study From China.
Ma X; Chen Z; An J; Zhang C
Clin Ther; 2024 May; ():. PubMed ID: 38821767
[TBL] [Abstract][Full Text] [Related]
20. Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment.
Ho CM; Chen CL; Chang CH; Lee MR; Wang JY; Hu RH; Lee PH
Biomedicines; 2021 Jul; 9(8):. PubMed ID: 34440095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]